Omics for Diagnosis, Disease Stratification and Therapy Selection
9:20 AM - 9:30 AM PST
VALIDATE-PERIANAL: AN INTERNATIONAL REAL-WORLD MULTI-CENTRE VALIDATION OF THE TOPCLASS DEFINITION OF A RADIOLOGICALLY HEALED FISTULA
Location: Tower Ballroom 2
Abstract Presenter: Sami Samaan, M.D – Washington University of St louis School of Medicine
Diagnostics in IBD
9:30 AM - 10:00 AM PST
Product Theater: Striving for Durable Outcomes in UC: A therapy that helps achieve powerful symptomatic and endoscopic outcomes for adult TNFi-IR patients with moderate to severe ulcerative colitis (AbbVie)
9:30 AM - 10:00 AM PST
Product Theater: Striving for Durable Outcomes in UC: A therapy that helps achieve powerful symptomatic and endoscopic outcomes for adult TNFi-IR patients with moderate to severe ulcerative colitis (AbbVie)
Location: Grand Ballroom
9:30 AM - 10:00 AM PST
33 - Refreshment Break in Exhibit Hall
9:30 AM - 10:00 AM PST
Refreshment Break
Location: Grand Ballroom
10:00 AM - 11:30 AM PST
34 - Therapeutic Chess: The Right Drug at the Right Time in IBD
Presenter: Marla C Dubinsky, MD (she/her/hers) – Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
10:00 AM - 11:30 AM PST
35 - Crypt to Villus: Intestinal Epithelial Stems Cells and Differentiation in Health and Inflammation (Basic Science Session)
TIME-RESOLVED CELL-CELL COMMUNICATION INFERENCE DURING ULCERATIVE COLITIS PROGRESSION
Location: Tower Ballroom 5
Abstract Presenter: Osafu A. Egbon, n/a – National Institute of Environmental Health Sciences, NIH
Intestinal Inflammation—Cell Signaling, Injury, Repair and Fibrosis
3:00 PM - 3:30 PM PST
Product Theater: TREMFYA® for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn’s Disease (Johnson & Johnson)
3:00 PM - 3:30 PM PST
Product Theater: TREMFYA® for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn’s Disease (Johnson & Johnson)
Location: Grand Ballroom
3:00 PM - 3:30 PM PST
39 - Refreshment Break in Exhibit Hall
3:00 PM - 3:30 PM PST
Refreshment Break
Location: Grand Ballroom
3:30 PM - 5:00 PM PST
40 - IBD in Balance: From Cancer Patrol to Flare Control
Health Care Delivery and Policy (Practice Management Including Telehealth, Reimbursement‚ Access to Care)
5:00 PM - 6:30 PM PST
STANDARDIZING IV TO SQ THERAPY TRANSITIONS IN IBD CARE: IMPLEMENTATION OF AN EPIC SMARTFORM TO STREAMLINE WORKFLOW AND REDUCE COMMUNICATION BURDEN IN IBD CLINIC
COMPARATIVE PERIOPERATIVE OUTCOMES OF LUMBAR SPINAL SURGERY IN PATIENTS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Location: Bellagio Ballroom
Poster Presenter: Bachviet AH Nguyen, MD – The University of British Columbia Department of Medicine
Health Disparities in Patients with GI Disease
5:00 PM - 6:30 PM PST
DEPRESSION AND RACIAL DISPARITIES IN CROHNS FLARE HOSPITALIZATIONS: A NATIONAL ANALYSIS, 2020-2021
IMPACT OF SOCIOECONOMIC DISPARITIES ON HOSPITAL OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CANCER
Location: Bellagio Ballroom
Poster Presenter: Anas Mardini, MD – St. mary and St. clare's general hospitals, NYMC
Health Disparities in Patients with GI Disease
5:00 PM - 6:30 PM PST
NEGLECTED DIFFERENCES: A META-EPIDEMIOLOGIC REVIEW OF SEX-DISAGGREGATED OUTCOME REPORTING IN ULCERATIVE COLITIS DRUG TRIALS
Location: Bellagio Ballroom
Poster Presenter: Nadia Smita, Premed – University of Texas Rio Grande Valley
Health Disparities in Patients with GI Disease
5:00 PM - 6:30 PM PST
SCHIZOPHRENIA, CROHN'S DISEASE, COLOSTOMY, AND POOR SOCIAL AND FAMILY SPUPORT: HOW AN INTEGRATED IBD TEAM MADE CARE POSSIBLE DESPITE HEALTHCARE DISPARITIES.
ARFID IN PEDIATRIC IBD: A MIXED METHODS STUDY EXPLORING THE PSYCHOSOCIAL IMPACT AND LIVED EXPERIENCE OF ARFID
Location: Bellagio Ballroom
Poster Presenter: Ashley Dunn, MPH (she/her/hers) – Stanford University School of Medicine, Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition
Quality of Life and Psychosocial Outcomes
5:00 PM - 6:30 PM PST
LEFT IN THE DARK, YET THE KEY TO SUCCESS: A PATIENT-LED SCOPING REVIEW OF PARENTAL NEEDS AND PERSPECTIVES SURROUNDING THE HEALTHCARE TRANSITION OF CHRONICALLY-ILL ADOLESCENTS AND YOUNG ADULTS
A SUBSET OF ALGORITHMIC BIOMARKERS DERIVED USING QUANTITATIVE AI BASED ON EVOLUTIONARY COMPUTATION THAT PREDICT TNF RESPONSE IN RHEUMATOID ARTHRITIS ALSO HAVE 100% ACCURACY PREDICTING TNF RESPONSE IN ULCERATIVE COLITIS, CROHN'S ILEITIS AND CROHN'S COLITIS
Location: Bellagio Ballroom
Poster Presenter: Kevin Horgan, MD – Melius MicroBiomics; Liquid Biosciences Inc.
Diagnostics in IBD
5:00 PM - 6:30 PM PST
DIAGNOSTIC ACCURACY OF AI AND RADIOMICS MODELS USING MRE AND CTE FOR HISTOLOGIC FIBROSIS IN CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Location: Bellagio Ballroom
Poster Presenter: Shiab Mussad, MD – Henry Ford Providence Southfield Hospital
Diagnostics in IBD
5:00 PM - 6:30 PM PST
IS A CALPROTECTIN A CALPROTECTIN: VARIATION IN CALPROTECTIN RESULTS BY METHODOLOGY
Location: Bellagio Ballroom
Poster Presenter: Thomas Wallach, MD – SUNY Downstate Health Sciences University
Diagnostics in IBD
5:00 PM - 6:30 PM PST
REAL-WORLD RISK STRATIFICATION IN CROHN'S DISEASE: PATTERNS IN DIAGNOSIS, TREATMENT, AND UTILIZATION
THE GREY AREA: DISCREPANCIES BETWEEN IBD RISK AND COLONOSCOPY RATES AT BORDERLINE CALPROTECTIN LEVELS
Location: Bellagio Ballroom
Poster Presenter: Thomas Wallach, MD – SUNY Downstate Health Sciences University
Diagnostics in IBD
5:00 PM - 6:30 PM PST
ACCELERATED INPATIENT INFLIXIMAB INDUCTION FOR PATIENTS HOSPITALIZED WITH ULCERATIVE COLITIS REDUCES RISK OF COLECTOMY AT 2 YEARS COMPARED TO STANDARD INDUCTION
ISM5411, A NOVEL GUT-RESTRICTED PHD1/2 INHIBITOR FOR INFLAMMATORY BOWEL DISEASE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIRST-IN-HUMAN PHASE I STUDY TO EVALUATE SAFETY, TOLERABILITY AND PK PROFILES
POSTER OF DISTINCTION: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 1 STUDY OF ATH-063: A NOVEL, ORAL, ARTIFICIAL INTELLIGENCE-GENERATED DRUG FOR INFLAMMATORY BOWEL DISEASE.
SAFETY AND EARLY EFFICACY SIGNALS OF THE FIRST-IN-CLASS DOPAMINE Β-HYDROXYLASE INHIBITOR APL-1401 IN MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS: PRIMARY RESULTS FROM A 4-WEEK RANDOMIZED PHASE 1B TRIAL
Location: Bellagio Ballroom
Poster Presenter: Xiaowei Liu, MD – Xiangya Hospital of Central South University
Controlled Clinical Trials in Humans
5:00 PM - 6:30 PM PST
ASSESSING THE RISK OF INFLAMMATORY BOWEL DISEASE FOLLOWING OCRELIZUMAB USE IN MULTIPLE SCLEROSIS PATIENTS: A RETROSPECTIVE ANALYSIS UTILIZING A LARGE NATIONAL DATABASE
COSTS PER RESPONSE AND REMISSION OF MIRIKIZUMAB VS RISANKIZUMAB IN THE MAINTENANCE PHASE FOR MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE TREATMENT IN THE UNITED STATES
PROFILE OF PATIENTS INITIATING MIRIKIZUMAB FOR ULCERATIVE COLITIS IN THE UNITED STATES
Location: Bellagio Ballroom
Poster Presenter: Jordan Axelrad, MD, MPH – Inflammatory Bowel Disease Center at NYU Langone Health
Uncontrolled Therapeutic Observations: Biologics
5:00 PM - 6:30 PM PST
REAL WORLD EXPERIENCE WITH MIRIKIZUMAB IN THE TREATMENT OF HIGHLY REFRACTORY AND PRETREATED (INCLUDING USTEKINUMAB) ULCERATIVE COLITIS. INTERIM-ANALYSIS FROM A LARGE EUROPEAN TERTIARY CENTER POPULATION
POSTER OF DISTINCTION: GLUCAGON-LIKE 1 RECEPTOR AGONIST USE WAS ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A LARGE REAL-WORLD DATABASE STUDY
Location: Bellagio Ballroom
Poster Presenter: Amanda M. Johnson, MD – Division of Gastroenterology & Hepatology, Mayo Clinic Rochester
RISK FACTORS FOR COLECTOMY FOLLOWING JANUS KINASE INHIBITOR RESCUE THERAPY IN ACUTE SEVERE ULCERATIVE COLITIS: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS
Microscopic Colitis, Drug-induced, and Other Enterocolitides: Clinical
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: ADJUNCTIVE GLP-1 RECEPTOR AGONISTS IN CROHNS DISEASE: REDUCED STEROID DEPENDENCE AND HOSPITALIZATIONS IN A REAL-WORLD MULTI-NETWORK COHORT
Location: Bellagio Ballroom
Poster Presenter: Nakul Ganju, MD – Howard University Hospital
Comparative Effectiveness Studies
5:00 PM - 6:30 PM PST
BIOLOGICS AND SMALL MOLECULE INHIBITORS FOR MUCOSAL HEALING IN ULCERATIVE COLITIS: A COMPARATIVE META-ANALYSIS OF ENDOSCOPIC OUTCOMES
POSTER OF DISTINCTION: COMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE (CATHARSIS) IS MET WITH EARLY ACCEPTABILITY AND HIGH EXPECTANCY
P051: ORAL MESALAMINE DOSING AND RESPONSE RATES IN ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND DOSE-RESPONSE META-ANALYSIS OF RANDOMIZED CONTROL TRIALS
Location: Bellagio Ballroom
Poster Presenter: Bachviet AH Nguyen, MD – The University of British Columbia Department of Medicine
Comparative Effectiveness Studies
5:00 PM - 6:30 PM PST
COMPARATIVE REAL WORLD OUTCOMES OF INTRAVENOUS VERSUS SUBCUTANEOUS VEDOLIZUMAB IN ULERCATIVE COLITIS AND CROHNS DISEASE
ABNORMAL PRE-OPERATIVE ANORECTAL MANOMETRY IS ASSOCIATED WITH INFLAMMATION OF THE RECTAL CUFF IN IPAA PATIENTS BUT NOT ENDOSCOPIC INFLAMMATORY POUCH DISEASE
ACUTE PANCREATITIS IN ULCERATIVE COLITIS: NATIONWIDE PREVALENCE, ETIOLOGIES, AND HEPATOBILIARY RISK FACTORS
Location: Bellagio Ballroom
Poster Presenter: Ahmed Abomhya, MBBS – Division of Digestive Diseases and Nutrition, University of Kentucky, College of Medicine
Disease Complications
5:00 PM - 6:30 PM PST
AN INTEGRATED MULTI-OMIC APPROACH REVEALS A SHARED SIGNATURE OF IMMUNE ACTIVATION AND METABOLIC COLLAPSE IN ULCERATIVE COLITIS AND RHEUMATOID ARTHRITIS
EVALUATING POUCH RELATED OUTCOMES WITH GLUCAGON LIKE PEPTIDE-1 RECEPTOR ANTAGONISTS IN PATIENTS WITH ILEAL POUCH ANAL ANASTOMOSIS - A DATABASE STUDY IN THE UNITED STATES
INCIDENCE OF EXTRAINTESTINAL MANIFESTATIONS IN IBD PATIENTS TREATED WITH ADVANCED THERAPIES
Location: Bellagio Ballroom
Poster Presenter: Marla C Dubinsky, MD (she/her/hers) – Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Disease Complications
5:00 PM - 6:30 PM PST
OPPORTUNISTIC FUNGAL INFECTIONS IN INFLAMMATORY BOWEL DISEASE: INCIDENCE, RISK FACTORS, AND OUTCOMES FROM A NATIONWIDE ANALYSIS
TREATMENT OF PYODERMA GANGRENOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY
Location: Bellagio Ballroom
Poster Presenter: Jessica Rueddel, MD (she/her/hers) – Department for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany
Disease Complications
5:00 PM - 6:30 PM PST
VENOUS THROMBOEMBOLISM AND INPATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE: EVIDENCE FROM THE NATIONWIDE INPATIENT SAMPLE
Location: Bellagio Ballroom
Poster Presenter: Anas Mardini, MD – St. mary and St. clare's general hospitals, NYMC
Disease Complications
5:00 PM - 6:30 PM PST
ALGORITHM DEVELOPMENT IN R TO CATEGORIZE RESPONSE TO ADVANCED THERAPUTICS IN THE STUDY OF A PROSPECTIVE ADULT RESEARCH COHORT WITH IBD
Location: Bellagio Ballroom
Poster Presenter: Ben Kostiuk, n/a – Crohn's & Colitis Foundation
Disease Activity Assessment and Monitoring
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: DEVELOPMENT OF A PREDICTIVE RISK CALCULATOR FOR ADVERSE EVENTS AND EMERGENCY DEPARTMENT UTILIZATION IN ULCERATIVE COLITIS
IMPACT OF ANTI-INFLAMMATORY DIET VERSUS HIGH-FIBER DIET ON SYMPTOMATIC REMISSION AND FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
Location: Bellagio Ballroom
Poster Presenter: Angela Minasyan, BS – David Geffen School of Medicine, University of California Los Angeles
Nutrition and IBD
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: LOW-DOSE SULFITE EXPOSURE DYSREGULATES EPITHELIAL AMINO ACID METABOLITES AND ENERGY METABOLISM IN PEDIATRIC COLON ORGANOIDS.
Location: Bellagio Ballroom
Poster Presenter: Sanmi Alake, n/a – Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Heersink School of Medicine, University of Alabama at Birmingham
Nutrition and IBD
5:00 PM - 6:30 PM PST
NO CHANGE IN CIRCULATING CYTOKINES IN ACTIVE CROHN'S DISEASE OR HEALTHY CONTROLS DURING HIGH AND LOW EMULSIFIER DIETS IN BLINDED FEEDING STUDIES
HOSPITALIZATION RATES FOR NON-VARICEAL UPPER GASTROINTESTINAL BLEEDS AMONG THOSE WITH INFLAMMATORY BOWEL DISEASE ARE DECREASING OVER TIME: A POPULATION-BASED COHORT STUDY
AVOIDANT RESTRICTIVE FOOD INTAKE DISORDER (ARFID) RISK BEHAVIORS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD): A HIDDEN BURDEN DESPITE CLINICAL REMISSION
Location: Bellagio Ballroom
Poster Presenter: Alka Goyal, MD (she/her/hers) – Stanford University School of Medicine, Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition
Pediatric IBD: Clinical and Translational Studies
5:00 PM - 6:30 PM PST
CLINICAL OUTCOMES OF ADALIMUMAB NONMEDICAL SWITCHES IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE
QUANTITATIVE SMALL BOWEL MOTILITY ASSESSMENT ON MAGNETIC RESONANCE ENTEROGRAPHY IN PEDIATRIC CROHN DISEASE: ASSOCIATIONS WITH CLINICAL PHENOTYPE AND SURGICAL OUTCOME
Location: Bellagio Ballroom
Poster Presenter: Marina Macchi, MD – Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA
Pediatric IBD: Clinical and Translational Studies
5:00 PM - 6:30 PM PST
REAL-WORLD DURABILITY OF BIOLOGICS IN PEDIATRIC IBD: INSIGHTS FROM THE KOREAN HIRA DATABASE
Location: Bellagio Ballroom
Poster Presenter: Jeehyeong Jang, MD – Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine
Pediatric IBD: Clinical and Translational Studies
5:00 PM - 6:30 PM PST
ADVANCED THERAPY AND NON-PELVIC SURGERY DO NOT AFFECT TIME TO PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE
Location: Bellagio Ballroom
Poster Presenter: Zoe S. Gottlieb, MD – Icahn School of Medicine at Mount Sinai
IBD in Special Populations: Conception, Adolescence and Older Adults
5:00 PM - 6:30 PM PST
IMPACT OF BODY MASS INDEX ON EFFICACY AND SAFETY OUTCOMES OF VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS: A POST HOC ANALYSIS OF THE VISIBLE 1 CLINICAL TRIAL
COHOUSING OF NON-INFLAMED MDR MICE WITH ILEOCOLITIC MDR MICE ALTERS THEIR COLONIC MICROBIOTA AND ATTENUATES ILEITIS IN ILEOCOLITIC MICE, WITHOUT INDUCING EITHER PHENOTYPE IN NON-INFLAMED COUNTERPARTS
Location: Bellagio Ballroom
Poster Presenter: Jesus Rivera-Nieves, MD – Division of Gastroenterology, University of California San Diego
Microbiome Role in Intestinal Inflammation
5:00 PM - 6:30 PM PST
MUCOSA-ASSOCIATED MICROBIOME IN INDIAN PATIENTS WITH ULCERATIVE COLITIS IS DYSBIOTIC, ENRICHED WITH PRO-INFLAMMATORY PATHOBIONTS, AND CHARACTERIZED BY AN ELEVATED FIRMICUTES/BACTEROIDETES RATIO
DIVERSITY LOSS DRIVES EARLY COLITIS IN A HIGH GENETIC RISK CROHN'S DISEASE MURINE MODEL
Location: Bellagio Ballroom
Poster Presenter: Shaheer Rizwan, MD – Department of Medicine, North Shore University Hospital/Long Island Jewish Medical Center
Role of the Gut Microbiome and Pathogens in Immune and Inflammatory Diseases
5:00 PM - 6:30 PM PST
CD8+ T-CELLS DEFINE SEX-SPECIFIC RESPONSES TO IL-23 TREATMENT IN CD
Location: Bellagio Ballroom
Poster Presenter: Erifili Lianopoulou, MSc – Institute for Bioinnovation, Biomedical Sciences Research Center “Alexander Fleming”
Cytokines, Signaling and Receptors
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: DENDRITIC CELL-SPECIFIC IL-36 RECEPTOR DEFICIENCY AMELIORATES COLONIC INFLAMMATION IN COLITIS
Location: Bellagio Ballroom
Poster Presenter: Shrikanth Chomanahalli Basavarajappa, Dr – 1) Trinity Translational Medicine Institute, School of Medicine, Trinity College Dublin, Ireland; 2) National Children’s Research Centre, CHI Crumlin, Dublin 12, Ireland.
Cytokines, Signaling and Receptors
5:00 PM - 6:30 PM PST
EXPLORING KAPPA OPIOID RECEPTOR MUTATIONS IN IBD: FROM MOLECULAR PHARMACOLOGY TO DRUG DISCOVERY
MACROCYCLIC AND STABILIZED DYNORPHIN PEPTIDES AS POTENT ANALGESICS FOR IBD PAIN MANAGEMENT
Location: Bellagio Ballroom
Poster Presenter: Elena C. A. Becker, M.Sc. – Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Vienna, Austria
Cytokines, Signaling and Receptors
5:00 PM - 6:30 PM PST
METABOLIC INFLAMMATION IN CROHN'S DISEASE: EFFECTS OF CARNITINE PAMITOYLTRANSFERASE ACTIVITY ON INFLAMMATORY SIGNALING IN THE INTESTINAL EPITHELIUM
Location: Bellagio Ballroom
Poster Presenter: Irina M. Geiculescu, MD – Emory University, Children's Healthcare of Atlanta
Cytokines, Signaling and Receptors
5:00 PM - 6:30 PM PST
Β7 INTEGRIN DEFICIENCY IMPAIRS B CELL GUT HOMING, DECREASES LUMINAL IGA LEADING TO DYSBIOSIS AND WORSENING OF CROHN’S LIKE MURINE ILEITIS
Location: Bellagio Ballroom
Poster Presenter: Zining Shen, n/a – University of California, San Diego
Immune Cells in Intestinal Inflammation
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: INNATE MEMORY IMPRINTED BY ORAL INFLAMMATION DRIVES PERSISTENT GUT INFLAMMATORY SUSCEPTIBILITY
Location: Bellagio Ballroom
Poster Presenter: Yeji Kim, PhD – University of Michigan
Immune Cells in Intestinal Inflammation
5:00 PM - 6:30 PM PST
TERTIARY LYMPHOID STRUCTURES (TLS) EXPANSION PARALLELS ILEITIS PROGRESSION IN TNFΔARE MICE, REQUIRES β7 INTEGRIN AND CCR7, AND DECREASES IN SIZE AFTER GLUCOCORTICOID ADMINISTRATION
Location: Bellagio Ballroom
Poster Presenter: Prabhdeep Kaur, n/a – University of California, San Diego, California
Immune Cells in Intestinal Inflammation
5:00 PM - 6:30 PM PST
COLONIC FOLDS AS IMMUNOLOGICAL AND LYMPHATIC HUBS OF THE LARGE INTESTINE
Location: Bellagio Ballroom
Poster Presenter: Rafael Czepielewski, PhD – Immunology Center of Georgia, Department of Physiology, Medical College of Georgia, Augusta University
Non-Immune Cells in Intestinal Inflammation
5:00 PM - 6:30 PM PST
INTESTINAL EPITHELIAL CELL-SPECIFIC DELETION OF JAK2 DISRUPTS GUT HOMEOSTASIS AND INCREASES INTESTINAL PERMEABILITY
Location: Bellagio Ballroom
Poster Presenter: Brooke B. D'Mello, n/a – Temerty Faulty of Medicine, University of Toronto, Toronto, Ontario, Canada
Non-Immune Cells in Intestinal Inflammation
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: PATHOLOGIC ALTERATIONS IN THE INTESTINAL EXTRACELLULAR MATRIX IN SMALL BOWEL CROHN'S DISEASE
Location: Bellagio Ballroom
Poster Presenter: Kendra Francis, MD – Seattle Children's Hospital/University of Washington
Non-Immune Cells in Intestinal Inflammation
5:00 PM - 6:30 PM PST
POSTER OF DISTINCTION: A HUMAN IPSC-DERIVED SCREENING MODEL FOR CROHN'S DISEASE DEMONSTRATES THE POTENTIAL ROLE OF JAK INHIBITORS IN MITIGATING INTESTINAL FIBROSIS
Intestinal Inflammation—Cell Signaling, Injury, Repair and Fibrosis
5:00 PM - 6:30 PM PST
GENETIC DELETION OF FAT REDUCES MUSCULARIS PROPRIA THICKNESS AND MUSCLE CELL PROLIFERATION IN CHRONIC DSS COLITIS-A POTENTIAL THERAPEUTIC TARGET FOR STRICTURING CROHN'S DISEASE
Intestinal Inflammation—Cell Signaling, Injury, Repair and Fibrosis
5:00 PM - 6:30 PM PST
METABOLITE MIMICRY REVEALS BUTYRATE ANALOG WITH SELECTIVE PROTECTIVE FUNCTIONS IN THE INTESTINAL MUCOSA
Location: Bellagio Ballroom
Poster Presenter: Alfredo Ornelas, PhD – Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado Anschutz Medical Campus
Intestinal Inflammation—Cell Signaling, Injury, Repair and Fibrosis
5:00 PM - 6:30 PM PST
PALI-2108, A COLON TARGETED PDE4B INHIBITOR, RAPIDLY RESTORES IMMUNE-EPITHELIAL BALANCE IN ULCERATIVE COLITIS THROUGHGUT-SELECTIVE LYMPHOCYTE DEPLETION
Intestinal Inflammation—Cell Signaling, Injury, Repair and Fibrosis
5:00 PM - 6:30 PM PST
UNCOVERING A MISSING TRANSCRIPTOMIC CORNERSTONE OF ILEAL FIBROSTENOSIS IN CROHN'S DISEASE: HUB GENE NETWORKS AND CANDIDATE SERUM BIOMARKERS FROM AN INTEGRATIVE RNA-SEQ STUDY
Intestinal Inflammation—Cell Signaling, Injury, Repair and Fibrosis
5:00 PM - 6:30 PM PST
COMPARATIVE RISK OF LYMPHOMA IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THIOPURINES AND/OR ANTI-TNF AGENTS: AN UMBRELLA REVIEW OF META-ANALYSES
POSTER OF DISTINCTION: GROL-ENRICHED EXTRACELLULAR VESICLES REGULATE HOST COPPER IMPORTER SLC31A1 TO ATTENUATE EPITHELIAL CUPROTOSIS IN ULCERATIVE COLITIS
Location: Bellagio Ballroom
Poster Presenter: Hailan Zhao, PhD – Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)
HYPOXIA-INDUCIBLE FACTOR REGULATION OF INTESTINAL AUTOPHAGY
Location: Bellagio Ballroom
Poster Presenter: Alexander S. Dowdell, PhD (he/him/his) – Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado Anschutz Medical Campus; Rocky Mountain Regional Veterans Affairs Medical Center
INDOLE ACETIC ACID AS AN INHIBITOR OF MYELOPEROXIDASE-MEDIATED BYSTANDER TISSUE DAMAGE IN INFLAMMATORY BOWEL DISEASE
Location: Bellagio Ballroom
Poster Presenter: Ji Yeon Kim, Ph.D – Mucosal Inflammation Program, Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado Anschutz Medical Campus
Animal Models of IBD: Pre-Clinical Treatment of Intestinal Inflammation
5:00 PM - 6:30 PM PST
DIFFERENTIAL STING ACTIVATION IN DENDRITIC CELLS SHAPES DISTINCT CD4 T CELL RESPONSES AND OPPOSING COLITIS OUTCOMES
Location: Bellagio Ballroom
Poster Presenter: Wenjing Yang, MD, PhD – Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Animal Models of IBD: Pre-Clinical Treatment of Intestinal Inflammation
5:00 PM - 6:30 PM PST
INTERMITTENT FASTING IMPROVES COLITIS OUTCOMES IN PRECLINICAL IBD MODELS: A META-ANALYSIS TO GUIDE HUMAN TRIALS
Animal Models of IBD: Pre-Clinical Treatment of Intestinal Inflammation
5:00 PM - 6:30 PM PST
A NOVEL TRUNCATING EP300 MUTATION IMPAIRS INTESTINAL EPITHELIAL DIFFERENTIATION IN PATIENT TISSUE AND ORGANOIDS AND CAN BE RESCUED BY CHEMICAL HDAC INHIBITION
